IRESSA - 0310-0482-30 - (Gefitinib)

Alphabetical Index


Drug Information of IRESSA

Product NDC: 0310-0482
Proprietary Name: IRESSA
Non Proprietary Name: Gefitinib
Active Ingredient(s): 250    mg/1 & nbsp;   Gefitinib
Administration Route(s): ORAL
Dosage Form(s): TABLET, COATED
Coding System: National Drug Codes(NDC)

Labeler Information of IRESSA

Product NDC: 0310-0482
Labeler Name: AstraZeneca Pharmaceuticals LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021399
Marketing Category: NDA
Start Marketing Date: 20030513

Package Information of IRESSA

Package NDC: 0310-0482-30
Package Description: 30 TABLET, COATED in 1 BOTTLE (0310-0482-30)

NDC Information of IRESSA

NDC Code 0310-0482-30
Proprietary Name IRESSA
Package Description 30 TABLET, COATED in 1 BOTTLE (0310-0482-30)
Product NDC 0310-0482
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Gefitinib
Dosage Form Name TABLET, COATED
Route Name ORAL
Start Marketing Date 20030513
Marketing Category Name NDA
Labeler Name AstraZeneca Pharmaceuticals LP
Substance Name GEFITINIB
Strength Number 250
Strength Unit mg/1
Pharmaceutical Classes Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]

Complete Information of IRESSA


General Information